Vertex Pharma Operating Cash Flow — Historical Data
Vertex Pharma (VRTX) operating cash flow was $3.6B in FY2025 (+837% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$3.6B
+837%
2024
-$493M
-114%
2023
$3.5B
-14%
2022
$4.1B
+56%
2021
$2.6B
-19%
2020
$3.3B
+107%
2019
$1.6B
+24%
2018
$1.3B
+50%
2017
$845M
+258%
2016
$236M
+165%
2015
-$365M
+36%
2014
-$573M
-845%
2013
-$61M
-123%
2012
$268M
+86%
2011
$144M
+123%
2010
-$635M
-49%
2009
-$428M
-89%
2008
-$226M
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q1 2026
$1.4B
Q4 2025
$498M
Q3 2025
$1.2B
Q2 2025
$1.1B
Q1 2025
$819M
Q4 2024
$585M
Q3 2024
$1.4B
Q2 2024
-$3.8B
Q1 2024
$1.3B
Q4 2023
$235M
Q3 2023
$1.3B
Q2 2023
$1.1B
Source: VRTX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.